Literature DB >> 27807109

Quality of Reduction Influences Outcome After Locked-Plate Fixation of Proximal Humeral Type-C Fractures.

Marc Schnetzke1, Julia Bockmeyer1, Felix Porschke1, Stefan Studier-Fischer1, Paul-Alfred Grützner1, Thorsten Guehring2.   

Abstract

BACKGROUND: The aim of this study was to determine if fracture reduction, fracture pattern, and patient-related factors influence clinical outcome after locked-plate fixation of displaced proximal humeral fractures.
METHODS: Ninety-eight patients (mean age, 61.1 ± 11.2 years) with a proximal humeral fracture involving the anatomical neck (type C according to the OTA/AO classification system) were included. Clinical outcome was determined by age and sex-adjusted Constant score (CS%) and the Disabilities of the Arm, Shoulder and Hand (DASH) score. Fracture reduction was quantitatively determined by 3 parameters (head-shaft displacement, head-shaft alignment, and cranialization of the greater tuberosity), and patients were divided into groups according to anatomical reduction, acceptable reduction, or malreduction. Relative risk (RR) for complications, revision surgery, and inferior clinical outcome (CS of <50%) was determined according to the quality of fracture reduction and fracture pattern (disruption of the medial hinge; type-C3 fracture) and patient-related factors (age; comorbidities).
RESULTS: After a mean of 3.1 ± 1.5 years, the mean CS% and DASH score were 54.8% ± 28.0% and 31.9 ± 24.8, respectively. The complication rate was 32.7% (n = 32), and 27 patients (27.6%) required revision surgery. Anatomical or acceptable fracture reduction was achieved in 40 (40.8%) of the patients. This resulted in a significantly lower complication rate (20.0% compared with 41.4% among the patients with malreduction; p = 0.027), a trend of lower revision rate (20% compared with 32.8%; p = 0.165), and better clinical outcome (mean CS% of 65.4% ± 28.2% compared with 47.6% ± 25.7%; p = 0.002) without a higher risk for osteonecrosis of the humeral head (5% compared with 10.3%). Cranialization of the greater tuberosity of >5 mm (n = 25), head-shaft displacement of >5 mm (n = 50), and valgus head-shaft alignment (n = 12) all increased the RR for inferior clinical outcome by twofold to threefold. Conversely, a patient age of >65 years (n = 31) and an OTA/AO type-C3 fracture pattern (n = 38) were not significantly associated with complications and inferior clinical outcome (RR, 0.9 to 1.8).
CONCLUSIONS: Anatomical fracture reduction with a locked plate significantly improved the clinical outcome of unstable and displaced proximal humeral fractures involving the anatomical neck. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
Copyright © 2016 by The Journal of Bone and Joint Surgery, Incorporated.

Entities:  

Mesh:

Year:  2016        PMID: 27807109     DOI: 10.2106/JBJS.16.00112

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  22 in total

Review 1.  [Post-traumatic necrosis of the humeral head-Endoprosthesis or joint preservation].

Authors:  A Wegner; D Wassenaar; A Busch; M Stanjek; C Mayer; M Jäger
Journal:  Orthopadie (Heidelb)       Date:  2022-09-09

Review 2.  Primary screw perforation or subsequent screw cut-out following proximal humerus fracture fixation using locking plates: a review of causative factors and proposed solutions.

Authors:  Tristan E McMillan; Alan J Johnstone
Journal:  Int Orthop       Date:  2017-10-07       Impact factor: 3.075

Review 3.  [Research progress on intra-articular screw penetration in proximal humeral fracture treated with locking plate].

Authors:  Bo Li; Wenfeng Xiong; Shimin Chang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-04-15

4.  Elevation of pro-inflammatory cytokine levels following anti-resorptive drug treatment is required for osteonecrosis development in infectious osteomyelitis.

Authors:  Mayu Morita; Ryotaro Iwasaki; Yuiko Sato; Tami Kobayashi; Ryuichi Watanabe; Takatsugu Oike; Satoshi Nakamura; Yosuke Keneko; Kana Miyamoto; Kazuyuki Ishihara; Yoichiro Iwakura; Ken Ishii; Morio Matsumoto; Masaya Nakamura; Hiromasa Kawana; Taneaki Nakagawa; Takeshi Miyamoto
Journal:  Sci Rep       Date:  2017-04-07       Impact factor: 4.379

5.  Cement augmentation of humeral head screws reduces early implant-related complications after locked plating of proximal humeral fractures.

Authors:  J Christoph Katthagen; O Lutz; C Voigt; H Lill; A Ellwein
Journal:  Obere Extrem       Date:  2018-01-30

6.  Rate of avascular necrosis after fracture dislocations of the proximal humerus: Timing of surgery.

Authors:  Marc Schnetzke; Julia Bockmeyer; Markus Loew; Stefan Studier-Fischer; Paul-Alfred Grützner; Thorsten Guehring
Journal:  Obere Extrem       Date:  2018-03-07

7.  Open reduction and internal fixation of displaced proximal humeral fractures. Does the surgeon's experience have an impact on outcomes?

Authors:  Tobias Helfen; Georg Siebenbürger; Evi Fleischhacker; Niklas Biermann; Wolfgang Böcker; Ben Ockert
Journal:  PLoS One       Date:  2018-11-06       Impact factor: 3.240

8.  Optimal viewing angles of intraoperative fluoroscopy for detecting screw penetration in proximal humeral fractures: a cadaveric study.

Authors:  Qiuke Wang; Yifei Liu; Ming Zhang; Yu Zhu; Lei Wang; Yunfeng Chen
Journal:  BMC Musculoskelet Disord       Date:  2018-09-07       Impact factor: 2.362

9.  Radiographic parameter(s) influencing functional outcomes following angular stable plate fixation of proximal humeral fractures.

Authors:  Marc-Daniel Ahrend; Luise Kühle; Stephan Riedmann; Sonja D Bahrs; Christian Bahrs; Patrick Ziegler
Journal:  Int Orthop       Date:  2021-03-23       Impact factor: 3.075

10.  Modified minimally invasive approach and intra-osseous portal for three-part proximal humeral fractures: a comparative study.

Authors:  Zhuo Zhang; Gongzi Zhang; Ye Peng; Xiang Wang; Hui Guo; Wei Zhang; Peifu Tang; Lihai Zhang
Journal:  J Orthop Surg Res       Date:  2018-02-01       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.